R. Bauer

Most-cited papers

1. Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes

   C. Gibbons, J. Blundell, Søren Tetens Hoff, K. Dahl +2 more

   2020Diabetes, obesity and metabolism135 citations Open access

   Semantic Scholar

   Save

2. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.

   J. Tanguay, A. Bell, M. Ackman, R. Bauer +8 more

   2013Canadian Journal of Cardiology112 citations

   Semantic Scholar

   Save

3. Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme

   V. Aroda, R. Bauer, E. Christiansen, M. Haluzík +4 more

   2022Diabetes, obesity and metabolism33 citations Open access

   Semantic Scholar

   Save

4. An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression

   I. Lingvay, R. Bauer, James Baker-Knight, J. Lawson +1 more

   2021Journal of Clinical Endocrinology and Metabolism19 citations Open access

   Semantic Scholar

   Save

5. 932-P: Efficacy and Safety of Oral Semaglutide by Baseline Age in the PIONEER Clinical Trial Program

   V. Aroda, R. Bauer, C. Hertz, E. Montanya +3 more

   2020Diabetes7 citations

   Semantic Scholar

   Save

6. 927-P: Effect of Oral Semaglutide with or without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4

   R. Pratley, R. Bauer, S. Inzucchi, K. Khunti +3 more

   2020Diabetes4 citations

   Semantic Scholar

   Save

7. Efficacy of oral semaglutide according to diabetes duration: An exploratory subgroup analysis of the PIONEER trial programme

   M. Hauser, M. Haluzík, R. Bauer, Jenny Casey Eriksson +3 more

   2021Diabetologie und Stoffwechsel3 citations

   Semantic Scholar

   Save

8. 57 - Efficacy and Safety of Oral Semaglutide by Baseline Age in the PIONEER Clinical Trial Program

   S. Pedersen, V. Aroda, R. Bauer, C. Hertz +3 more

   20202 citations

   Semantic Scholar

   Save

9. Designing a commercial bundle for cardiac procedures: The Percutaneous Coronary Intervention Episode Payment Model.

   John W. Urwin, R. Bauer, J. Cunningham, Tyler Oleksy +9 more

   2020Healthcare2 citations

   Semantic Scholar

   Save

10. EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE

    Margarida Augusto, R. Bauer, Simon Clancy, A. Poulsen +2 more

    2026JHEP Reports1 citations Open access

    Semantic Scholar

    Save

11. 664-P: Incorporating Treatment Pauses, Dosing Flexibility, and Education to Support GLP-1RA Therapy Persistence

    V. Aroda, R. Bauer, A. Davies, E. Kreiner +3 more

    2021Diabetes1 citations

    Semantic Scholar

    Save

12. Incorporating Treatment Pauses, Dosing Flexibility and Education to Support GLP-1RA Therapy Persistence

    V. Aroda, R. Bauer, A. Davies, E. Kreiner +3 more

    2021Canadian Journal of Diabetes1 citations

    Semantic Scholar

    Save

13. Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction‐Associated Steatohepatitis

    Joe Hollinghurst, Margarida Augusto, F. Tefos, R. Bauer +2 more

    2026Diabetes, obesity and metabolism0 citations Open access

    Semantic Scholar

    Save

14. 56 - Effect of Oral Semaglutide With or Without Background SGLT2i in Patients With T2D: Subgroup Analysis of PIONEER 4

    R. Goldenberg, R. Pratley, R. Bauer, K. Khunti +3 more

    20200 citations

    Semantic Scholar

    Save

15. Author response for "Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes"

    C. Gibbons, J. Blundell, S. Hoff, K. Dahl +2 more

    20200 citations

    Semantic Scholar

    Save

16. The CIRSE Research Infrastructure: our 5-year experience

    C. Rse, R. Bauer

    20180 citations

    Semantic Scholar

    Save